Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms

Expression of apoptosis-related proteins, bcl-2, Bar, Fas and Fas ligand (L ), in ovarian epithelial neoplasms together with its clinical relevance was examined by immunohistochemistry. They included 36 cases with adenoma, 33 with low potential malignancy (LPM) and 63 with carcinomas. bcl-2 expressio n was observed in 14 of 36 cases (39%) with adenoma, five of 33 (15%) with LPM (P < 0.05) and 12 of 63 (19%) with carcinoma (P < 0.05). Cases with bcl -2 expression showed more favourable prognosis than those without, but the difference was not statistically significant There was no difference in fre quency of Bar and Fas expression between each histologic category. Fas L ex pression was observed in one of 36 cases (3%) with adenoma, but in 12 of 33 (36%) with LPM (P < 0.001) and 42 of 63 (67%) with carcinoma (P < 0.0001). In carcinomas, cases expressing Fas L showed a less favourable prognosis t han those without (P = 0.02). Density of CD8(+) lymphocytes, possibly cytot oxic T-cells, was higher in serous carcinoma with negative Fas L expression than those with positive Fas L expression. These findings suggest that Fas L expressing carcinomas induce apoptosis in infiltrating CTL with Fas expr ession, and escape from immune surveillance. (C) 2000 Cancer Research Campa ign.